Kissei Pharmaceutical Co Ltd
TSE:4547
Kissei Pharmaceutical Co Ltd
TSE:4547
Price:
3 055 JPY
-2.55%
Market Closed
Updated:
May 29, 2024
Kissei Pharmaceutical Co Ltd
Capital Expenditures
|
Kissei Pharmaceutical Co Ltd
Capital Expenditures Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Kissei Pharmaceutical Co Ltd
TSE:4547
|
Capital Expenditures
-¥1.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
1%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Capital Expenditures
-¥480.7B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-20%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Capital Expenditures
-¥122.8B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Capital Expenditures
-¥132.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-7%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Capital Expenditures
-¥74.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-16%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Capital Expenditures
-¥82.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-4%
|
See Also
What is Kissei Pharmaceutical Co Ltd's Capital Expenditures?
Capital Expenditures
-1.8B
JPY
-1.8B
JPY
Based on the financial report for Mar 31, 2024, Kissei Pharmaceutical Co Ltd's Capital Expenditures amounts to -1.8B JPY.
What is Kissei Pharmaceutical Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
1%
1%
Over the last year, the Capital Expenditures growth was 28%. The average annual Capital Expenditures growth rates for Kissei Pharmaceutical Co Ltd have been -7% over the past three years , -7% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
